primary%20open-angle%20glaucoma
PRIMARY OPEN-ANGLE GLAUCOMA
Primary open-angle glaucoma (POAG) is a chronic, progressive, usually bilateral disease of the eye with an insidious onset.
It is most often characterized by optic nerve damage, defects in the retinal fiber layer and subsequent visual field loss in the absence of underlying ocular disease or congenital abnormalities.
It is generally asymptomatic until it has caused a significant loss of visual field.
Occasionally, patients with very high intraocular pressure may complain of nonspecific headache, discomfort, intermittent blurring of vision or even halos caused by corneal edema.

Primary Open-Angle Glaucoma Drug Information

Drug Information
Tapcom-S
tafluprost + timolol maleate

Indication: Reduction of IOP in adult patients w/ open angle glaucoma or ocular HTN who are insufficiently responsive to t...

Indication: Reduction of elevated IOP in patients w/ ocular HTN, chronic open-angle glaucoma, aphakia & glaucoma, seco...

Indication: Decrease of elevated IOP in patients w/ ocular HTN or open-angle glaucoma.

Indication: Elevated IOP in patients w/ ocular HTN or open-angle glaucoma.

Indication: Elevated IOP in patients w/ ocular HTN, open-angle glaucoma.

Indication: Reduction of elevated IOP in patients w/ open-angle glaucoma, chronic angle-closure glaucoma & ocular HTN.

Indication: Reduction of IOP in patients w/ open angle glaucoma & ocular HTN who are insufficiently responsive to topi...

Indication: Reduction of elevated IOP in patients w/ open angle & chronic angle closure glaucoma & ocular HTN.

2  /  3
Editor's Recommendations
Most Read Articles
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.